US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

FOXO Technologies Inc.

0.0112

-0.0100-47.17%

Volume:50.50K

Turnover:565.60

Market Cap:- -

PE:- -

High:0.0112

Open:0.0112

Low:0.0112

Close:0.0212

Loading ...

Overview Company News Filings

Company Profile

Company Name:

FOXO Technologies Inc.

Exchange:

PINK

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

- -

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

FOXO Technologies Inc. engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and FOXO Life, a sales and distribution platform focused on recruiting independent life insurance agents to sell life insurance with the Longevity Report. The company was founded in 2020 and is based in Minneapolis, Minnesota. FOXO Technologies Inc. is a subsidiary of FOXO Management LLC.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/FOXOW/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FOXOW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FOXOW\",,,,,undefined,":{"symbol":"FOXOW","market":"US","secType":"STK","nameCN":"FOXO Technologies Inc.","latestPrice":0.0112,"timestamp":1749844800000,"preClose":0.0212,"halted":0,"volume":50500,"delay":15,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-0.01,"latestTime":"06-13 16:00:00 EDT Delay","open":0.0112,"high":0.0112,"low":0.0112,"amount":565.6,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750060800000},"marketStatusCode":7,"adr":0,"exchange":"PINK","adjPreClose":0.0212,"volumeRatio":12.230564864085085},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FOXOW\",,,,,undefined,":{"symbol":"FOXOW","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":12.230564864085085,"shares":0,"dividePrice":0,"high":0.0112,"amplitude":0,"preClose":0.0212,"low":0.0112,"week52Low":0.001,"pbRate":"--","week52High":0.06,"institutionHeld":0,"latestPrice":0.0112,"eps":0,"divideRate":0,"volume":50500,"delay":15,"open":0.0112,"prevYearClose":0.0215,"prevWeekClose":0.012,"prevMonthClose":0.03,"prevQuarterClose":0.0093,"fiveDayClose":0.012,"twentyDayClose":0.012,"sixtyDayClose":0.011},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"description":"FOXO Technologies Inc. engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and FOXO Life, a sales and distribution platform focused on recruiting independent life insurance agents to sell life insurance with the Longevity Report. The company was founded in 2020 and is based in Minneapolis, Minnesota. FOXO Technologies Inc. is a subsidiary of FOXO Management LLC.","exchange":"PINK","name":"FOXO Technologies Inc.","nameEN":"FOXO Technologies Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"FOXOW\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FOXOW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FOXOW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FOXOW\",market:\"US\",delay:false,,,undefined,":{}}}